Research article summary (published 19 Sep 2009):

Can erythropoietin improve developmental outcomes for preterm infants?

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: McPherson, Ronald J (RJ);

Affiliation: Department of Pediatrics, University of Washington, Seattle, Washington 98195,USA. neuron(-atsign-)uw.edu

Journal and publication information

Publication Type: Journal Article

Journal: Pediatrics (Pediatrics), published in United States. (Language: eng)

Reference: 2009-Oct; vol 124 (issue 4) : pp e805-6

Dates: Created 2009/10/05; Completed 2009/10/23;

PMID: 19770176, status: MEDLINE (last retrieval date: 10/23/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Child Development - drug effects Developmental Disabilities - prevention & control Dose-Response Relationship, Drug Drug Administration Schedule Drug Toxicity Erythropoietin, Recombinant - administration & dosage; adverse effects Female Follow-Up Studies Humans

Humans Infant Infant, Newborn Infant, Premature Male Risk Assessment Treatment Outcome United States United States Food and Drug Administration

Associated Chemicals: Erythropoietin, Recombinant (0)

Related articles

These are the highest related articles currently in the database:

• Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide. 29 Jun 2007
• The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants. 30 Oct 2005
• Prenatal cocaine exposure and neonatal/infant outcomes. 30 Dec 2002
• An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. 30 Jul 2008
• Behavioral outcomes in low birth weight infants. 30 Oct 1998
• Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. 12 Aug 2006
• Effect of early neurodevelopmental therapy in normal and at-risk survivors of neonatal intensive care. 12 Dec 1985
• Facilitation of parenting the premature infant within the newborn intensive care unit. 30 May 2002
• Outcome of 100 randomly positioned children of very low birthweight at 2 years. 30 Dec 1990
• A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. 30 Jul 2008

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.